Alterations in Androgen Conjugate Levels in Women and Men with Alopecia

    October 1994 in “ Fertility and Sterility
    Richard S. Legro, Enrico Carmina, Frank Z. Stanczyk, Elisabet Gentzschein, Rogerio A. Løbo
    Image of study
    TLDR People with hair loss may have different levels of certain hormones due to changes in hormone processing.
    In 1994, a study was conducted to examine androgen metabolite levels in individuals with alopecia. The study included 10 female controls, 50 hyperandrogenic women (with subgroups based on hirsutism and alopecia), 10 normal men, and 10 young men with premature balding. The results indicated that hyperandrogenic women, both with and without alopecia, had elevated levels of testosterone, androstenedione, and DHEAS compared to controls. Women with androgenic alopecia showed higher levels of certain androgens, suggesting increased 5α-reductase activity and a preference for sulfurylation over glucuronidation in androgen metabolism. Men with premature balding had lower levels of 3α-androstanediol glucuronide, also pointing to altered androgen conjugation. The study concluded that both increased 5α-reductase activity and changes in androgen conjugation may play a role in the development of androgenic alopecia.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 728 results

      community Proof that finasteride messes with neurosteroids

      in Research/Science  230 upvotes 7 months ago
      Finasteride can impact neurosteroids, potentially causing depression and other side effects in some users. Despite these concerns, many continue using it for hair loss, with some switching to topical applications to mitigate side effects.

      community Insane Idea: Cyperus Rotundus Oil?

      in Research/Science  9 upvotes 4 months ago
      Cyperus rotundus oil is suggested as a natural treatment for androgenic alopecia, potentially inhibiting hair growth without affecting testosterone levels. The conversation questions its effectiveness and safety for scalp use.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 6 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Related Research

    1 / 1 results